
People diagnosed with advanced cancer can face a host of challenges and stresses, from navigating the health care system to dealing with relationship disruptions and figuring out how to spend the time […]
1) Findings: Insights and developments globally on the subject of cancer.
2) Companies: Updates and progress reports on Consortium member companies.
3) Industry: Important developments from throughout the field of cancer.
People diagnosed with advanced cancer can face a host of challenges and stresses, from navigating the health care system to dealing with relationship disruptions and figuring out how to spend the time […]
In a proof-of-concept study performed in primates, frozen immature testicular tissue has been successfully used for the conception and birth of a baby monkey. Although human trials are needed before the technique […]
As cancer progresses, it often leads to physical disability and pain that can threaten a person’s independence and devastate their quality of life. Yet most people with advanced cancer don’t receive physical therapy or engage […]
For patients with a brain tumor, the first step in treatment is often surgery to remove as much of the mass as possible. A tumor sample obtained and analyzed during surgery can […]
Medical professionals and researchers are continuously finding incredible breakthroughs in cancer treatment. As treatment options continue to progress, Linda Giardinello founder of New York Institute of Beauty, has identified a major gap in […]
Pancreatic cancer made headlines throughout 2019 after both Jeopardy! host Alex Trebek and U.S. Congressman John Lewis were diagnosed with the devastating illness. Although curable when caught early, pancreatic cancer often does not cause symptoms […]
A new study in mice suggests that a biological process known as cellular senescence, which can be induced by cancer treatments, may play a role in bone loss associated with chemotherapy and […]
Over the course of several decades, NCI scientists laid extensive groundwork for a novel treatment that would eventually go on to become axicabtagene ciloleucel (Yescarta), a CAR T-cell therapy for adults with lymphoma. While the therapy […]